Frank Buchholz

27PUBLICATIONS
81CO-AUTHORS
Molecular targetsPredictive and prognostic markersElectrochemical energy storage and conversionSeparation technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Mar 27, 2025
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers.

Vida Kufrin, Annika Seiler, Silke Brilloff

|Feb 06, 2025
Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C.

Franziska Maria Schwarz, Daniel Martin Klotz, Ruming Yang

|Jun 13, 2024
Engineering spacer specificity of the Cre/loxP system.

Jenna Hoersten, Gloria Ruiz-Gómez, Maciej Paszkowski-Rogacz

|Jan 31, 2024
Activation of recombinases at specific DNA loci by zinc-finger domain insertions.

Liliya Mukhametzyanova, Lukas Theo Schmitt, Julia Torres-Rivera

Pageof 5